Development and spontaneous closure of a secondary macular hole associated with submacular hemorrhage due to polypoidal choroidal vasculopathy: a case report.
Aged
Choroid
/ blood supply
Choroid Diseases
/ complications
Fluorescein Angiography
/ methods
Follow-Up Studies
Fundus Oculi
Humans
Macula Lutea
/ pathology
Male
Polyps
/ complications
Remission, Spontaneous
Retinal Hemorrhage
/ complications
Retinal Perforations
/ diagnosis
Tomography, Optical Coherence
/ methods
Visual Acuity
Macular hole
Retinal displacement
Spontaneous closure
Submacular hemorrhage
Journal
BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802
Informations de publication
Date de publication:
17 Mar 2020
17 Mar 2020
Historique:
received:
25
11
2019
accepted:
04
03
2020
entrez:
19
3
2020
pubmed:
19
3
2020
medline:
29
1
2021
Statut:
epublish
Résumé
Macular hole (MH) is a retinal break in the fovea involving partial or complete dehiscence of the neural retinal layers affecting the visual quality by decreasing visual acuity (VA) and visual deformation. We describe a case of secondary MH associated with submacular hemorrhage (SMH) due to polypoidal choroidal vasculopathy (PCV), which showed spontaneous closure. A 67-year-old man developed decreased VA in his right eye due to an SMH. The VA was 20/50, and monthly intravitreal injection of aflibercept was administered three times. The SMH gradually decreased, and 10 months later the external limiting membrane was found to be perforated, resulting in MH. The old clot disappeared, and the MH remained for 10 months. Twenty-three months later, serous retinal detachment (SRD) involving the macula appeared and the MH had disappeared. SRD gradually disappeared, and macular configuration recovered. VA gradually improved and became 20/20 38 months later. Dynamic change of the ultrastructure in an unusual case of secondary-developed and spontaneously closed MH was clearly observed. Although the mechanism was unknown, the small diameter size and exudative PCV are thought to have contributed to the closure.
Sections du résumé
BACKGROUND
BACKGROUND
Macular hole (MH) is a retinal break in the fovea involving partial or complete dehiscence of the neural retinal layers affecting the visual quality by decreasing visual acuity (VA) and visual deformation. We describe a case of secondary MH associated with submacular hemorrhage (SMH) due to polypoidal choroidal vasculopathy (PCV), which showed spontaneous closure.
CASE PRESENTATION
METHODS
A 67-year-old man developed decreased VA in his right eye due to an SMH. The VA was 20/50, and monthly intravitreal injection of aflibercept was administered three times. The SMH gradually decreased, and 10 months later the external limiting membrane was found to be perforated, resulting in MH. The old clot disappeared, and the MH remained for 10 months. Twenty-three months later, serous retinal detachment (SRD) involving the macula appeared and the MH had disappeared. SRD gradually disappeared, and macular configuration recovered. VA gradually improved and became 20/20 38 months later.
CONCLUSION
CONCLUSIONS
Dynamic change of the ultrastructure in an unusual case of secondary-developed and spontaneously closed MH was clearly observed. Although the mechanism was unknown, the small diameter size and exudative PCV are thought to have contributed to the closure.
Identifiants
pubmed: 32183733
doi: 10.1186/s12886-020-01370-8
pii: 10.1186/s12886-020-01370-8
pmc: PMC7079491
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108Subventions
Organisme : Japan Society for the Promotion of Science
ID : KAKENHI grant number: 17K11430
Références
J Ophthalmol. 2019 Mar 13;2019:4793764
pubmed: 31001430
Ophthalmic Surg Lasers Imaging. 2011 Nov-Dec;42(6):516-8
pubmed: 21877680
Eur J Ophthalmol. 2008 May-Jun;18(3):462-5
pubmed: 18465735
Retina. 2018 Apr;38(4):660-663
pubmed: 28816729
Graefes Arch Clin Exp Ophthalmol. 2007 Apr;245(4):609-11
pubmed: 16871381
Graefes Arch Clin Exp Ophthalmol. 2008 Dec;246(12):1779-82
pubmed: 18766365
Am J Ophthalmol. 1991 Feb 15;111(2):197-204
pubmed: 1899537
Arch Ophthalmol. 1991 May;109(5):723-9
pubmed: 2025175
Am J Ophthalmol. 2003 Apr;135(4):487-92
pubmed: 12654365
Sci Rep. 2015 Jul 21;5:12343
pubmed: 26196460
Korean J Ophthalmol. 2019 Apr;33(2):198-199
pubmed: 30977331
Br J Ophthalmol. 2008 Feb;92(2):217-9
pubmed: 18227202
Retina. 2019 Oct;39 Suppl 1:S84-S86
pubmed: 29489566
Am J Ophthalmol. 2002 Feb;133(2):230-5
pubmed: 11812427
Clin Exp Optom. 2011 Nov;94(6):586-8
pubmed: 21517972
Am J Ophthalmol Case Rep. 2018 Dec 05;13:59-61
pubmed: 30582073
Medicine (Baltimore). 2019 Jan;98(4):e14230
pubmed: 30681603
Acta Ophthalmol. 2009 Mar;87(2):235-7
pubmed: 19292858
Eye (Lond). 2013 Jul;27(7):871-7
pubmed: 23703632
Ophthalmology. 2013 Dec;120(12):2611-2619
pubmed: 24053995
J Ophthalmol. 2019 Mar 19;2019:5837832
pubmed: 31016038
Arch Ophthalmol. 2000 Jun;118(6):780-5
pubmed: 10865314
Am J Ophthalmol. 2007 Mar;143(3):504-5
pubmed: 17317395
JAMA Ophthalmol. 2016 May 1;134(5):604-606
pubmed: 26941005
Jpn J Ophthalmol. 2007 Jan-Feb;51(1):76-7
pubmed: 17295150
Br J Ophthalmol. 2009 Oct;93(10):1337-40
pubmed: 19520697